Author

Marieke van de Ven

The Netherlands Cancer InstituteORCID 0000-0001-6779-9353Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Molecular Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Organism:mouse· 2 Research Focus:cell type annotation· 1 Assay:scRNA-seq· 1

Frequent Co-Authors

Aleksandra BalwierziD· 1 shared Alexandra A. Duarte· 1 shared Baojie ZhangiD· 1 shared Claudia Y. JandaiD· 1 shared Diego DibitettoiD· 1 shared Ewa GogolaiD· 1 shared Ismar Klebic· 1 shared Israel SalgueroiD· 1 shared

Activity by Year

2022-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Aleksandra BalwierzORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Cancer BiologyJBMR PlusPeer-reviewedSep 3, 2025

Mechanisms of dexamethasone-induced bone toxicity in developing bone: a single-cell perspective

Kelly Warmink, Philip Lijnzaad, Stephanie A Schubert…·Claudia Y. Janda

This study investigates dexamethasone-induced bone toxicity in developing bones using single-cell transcriptomics in mice, revealing reduced osteoblast and chondrocyte populations and disrupted B cell development.

6 citations

mousescRNA-seq

𝕏 PostBluesky

Molecular BiologybioRxivPreprintAug 18, 2022

MDC1 counteracts restrained replication fork restart and its loss causes chemoresistance in BRCA1/2-deficient mammary tumors

Martin Liptay, Joana S. Barbosa, Ewa Gogola…·Sven Rottenberg

This study identifies MDC1's role in replication fork restart and shows its loss leads to chemoresistance in BRCA1/2-deficient mammary tumors.

6 citations

mouseexperimental assay

𝕏 PostBluesky